“ Evaluation of Soluble PD-1 and PD-L1 in Iraqi Type 2 Diabetes Mellitus (T2DM) Patients with Chronic Toxoplasmosis” (2020) Medico Legal Update, 20(3), pp. 609–615. doi:10.37506/mlu.v20i3.1467.